BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9570238)

  • 21. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.
    Bauer A; Habior A
    J Clin Lab Anal; 2007; 21(4):227-31. PubMed ID: 17621358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis.
    Wesierska-Gadek J; Hohenuer H; Hitchman E; Penner E
    Gastroenterology; 1996 Mar; 110(3):840-7. PubMed ID: 8608894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of antinuclear antibodies in primary biliary cirrhosis.
    Gao L; Tian X; Liu B; Zhang F
    Clin Exp Med; 2008 Mar; 8(1):9-15. PubMed ID: 18385935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
    Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
    J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
    Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
    Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
    Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
    Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
    Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
    Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How to understand the clinical significance of autoantibodies in primary biliary cholangitis].
    Yan HP; Zhang HP; Chen XX
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):810-815. PubMed ID: 29325273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
    Courvalin JC; Lassoued K; Worman HJ; Blobel G
    J Exp Med; 1990 Sep; 172(3):961-7. PubMed ID: 2167346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC.
    Miyachi K; Shibata M; Onozuka Y; Kikuchi F; Imai N; Horigome T
    Mol Biol Rep; 1996; 23(3-4):227-34. PubMed ID: 9112233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
    Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
    Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis.
    Granito A; Muratori P; Quarneti C; Pappas G; Cicola R; Muratori L
    Expert Rev Mol Diagn; 2012 Jan; 12(1):65-74. PubMed ID: 22133120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.